CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients

Link to the original source: https://www.nature.com/articles/s41423-019-0275-4

APA: Vitallé J, Terrén I, Orrantia A, Pérez-Garay R, Vidal F, Iribarren JA, Rodríguez C, Lirola AML, Bernal E, Zenarruzabeitia O, Borrego F (2019). CD300a inhibits CD16-mediated NK cell effector functions in HIV-1-infected patients. Cellular & Molecular Immunology, 16(12), 940-942. DOI: 10.1038/s41423-019-0275-4

Paper original source: Cellular & Molecular Immunology. 16 (12): 940-942

Article's DOI: 10.1038/s41423-019-0275-4

Journal publication year: 2019

Entity: Universitat Rovira i Virgili

Paper version: info:eu-repo/semantics/publishedVersion

Record's date: 2024-11-16

URV's Author/s: Vidal Marsal, Francisco

Department: Medicina i Cirurgia

Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/

Publication Type: Journal Publications

ISSN: 16727681

Author, as appears in the article.: Vitallé J, Terrén I, Orrantia A, Pérez-Garay R, Vidal F, Iribarren JA, Rodríguez C, Lirola AML, Bernal E, Zenarruzabeitia O, Borrego F

licence for use: https://creativecommons.org/licenses/by/3.0/es/

Thematic Areas: Medicine (miscellaneous), Medicina iii, Medicina ii, Medicina i, Infectious diseases, Immunology and allergy, Immunology, Farmacia, Ciências biológicas i

Author's mail: francesc.vidal@urv.cat